BSE filing, NSE: AVONLIFE. Summary written from the filing by ALFA Finder's alert engine.
Kobo Biotech Ltd: key numbers
- Share price
- ₹3.94
- Market cap
- ₹9.39 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-4.93 Cr
- P/E (TTM)
- -1.9×Sector 46.1×
- Promoter holding
- 44.95%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kobo Biotech Ltd
All →Kobo Biotech Insolvency Petition
NCLT appointed Rajat Mukherjee as Chairman of Kobo Biotech's Monitoring Committee, replacing resigning Resolution Professional Namrata Randeri. The CoC had already approved the appointment.
Kobo Biotech Annual General Meeting
Kobo Biotech Ltd conducted its 31st Annual General Meeting on July 24, 2026. Shareholders passed the ordinary resolution for adoption of annual accounts and reports.
Kobo Biotech Insolvency Petition
Kobo Biotech reports that Beaufond Industries failed to implement the NCLT-approved resolution plan by the July 10 deadline. A Monitoring Committee meeting is convened for further action.
- Execution
- Implementation was due by 10 July 2026
Kobo Biotech Annual Report
Kobo Biotech Ltd submitted its Annual Report for FY 2023-24. The 31st AGM is scheduled for July 24, 2026.
Kobo Biotech Insolvency Petition
NCLT approved Beaufond Industries' ₹70.11 Crore resolution plan for Kobo Biotech. The plan involves a merger, fresh equity issuance, and settlement of all existing liabilities.
- Value
- ₹70.11 Cr
Kobo Biotech Insolvency Petition
NCLT approved Beaufond Industries' ₹70.11 Crore resolution plan for Kobo Biotech Limited. The plan ensures business continuity through debt settlement and restructuring.
- Value
- ₹70.11 Cr
- Execution
- 60 days
Other debt & borrowing announcements
All →Fusion CX Debt & Borrowing: ₹21.85 Cr
Fusion CX lent up to Rs.21.85 Crore (USD 2.3 million) to wholly owned subsidiary Fusion BPO Services. Terms: 8.5% interest, three-year tenure, unsecured.
- Value
- ₹21.85 Cr
- Execution
- 3 years from the date of disbursal
Fusion CX Debt & Borrowing
Fusion CX Limited executed an unsecured inter-corporate term loan at 8.5% p.a. for three years with its wholly owned subsidiary Fusion BPO Services Ltd, a related party. Amount is not stated in the filing.
- Execution
- 3 years from the date of disbursal
Spandana Sphoorty Financial Debt & Borrowing: ₹0.49 Cr
Spandana paid ₹0.49 Crore of quarterly interest on its secured NCDs on 27 October 2026. The coupon rate is 10.75% on a ₹50 Crore issue.
- Value
- ₹0.49 Cr
Mangalam Worldwide Debt & Borrowing: ₹1.14 Cr
Mangalam Worldwide paid Rs. 1.14 Crore interest on its NCDs (ISIN INE0JYY07026) on 28 October 2026, net of TDS. The company confirmed timely payment under Regulation 57.
- Value
- ₹1.14 Cr
Lloyds Metals & Energy Debt & Borrowing: ₹12,370 Cr
Lloyds Metals allotted 1,300 debt securities worth about ₹12,370 Crore on 29 October 2026. Three-year coupon is SOFR plus 450 bps, secured by Virtus Lloyds share pledges.
- Value
- ₹12,370 Cr
- Execution
- 3 years
Lloyds Metals & Energy Debt & Borrowing: ₹1,235 Cr
Lloyds Metals' committee approved terms for USD 130 million senior secured notes, about Rs.1,235 Crore. The notes mature in October 2029 at SOFR plus 450 bps.
- Value
- ₹1,235 Cr